Sixteen out of 18 sows and all 15 pigs for meat vaccinated were healthy after two months.
An Indian vaccine manufacturing company has collaborated with a global research and development organization to produce an oral cholera vaccine for India and several other low and middle-income countries.
Access to conjugate vaccines is limited due to centralized production and cold chain distribution requirements. To combat these challenges, researchers developed a modular technology for in vitro bioconjugate vaccine expression in portable, freeze-dried lysates.
A highly effective Ebola vaccine that has been used for the first time during the current Ebola outbreak in the Democratic Republic of Congo (DRC) is in limited supply prompting a discussion of if and how to deploy a second new Ebola vaccine to supplement the limited supplies.
Researchers assessed whether a new component (pH1N1) of an existing influenza vaccine resulted in greater shedding and immunogenicity.
Somalia has launched an immunization campaigns using oral cholera vaccines. The campaign will vaccinate more than 650,000 people.
Researchers identified more than thirty African swine fever virus proteins that are recognized by lymphocytes from African swine fever immune pigs which led to increased knowledge of the determinants of the cellular immune response to the virus.
The trial will evaluate the immunogenicity and safety of three consecutive vaccine lots of the freeze-dried formulation of MVA-BN®smallpox vaccine.
A new technique that mimics the way the body copies its own DNA may allow the creation of a gene in a single day.
Researchers developed a new vaccine against anthrax that can generate an immune response to anthrax toxin as well as its spores rather than just the toxin as existing vaccines do.